ClinVar Miner

Submissions for variant NM_001037.5(SCN1B):c.623A>T (p.Lys208Ile) (rs780958012)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000553474 SCV000647847 uncertain significance Brugada syndrome 5 2018-08-16 criteria provided, single submitter clinical testing This sequence change replaces lysine with isoleucine at codon 208 of the SCN1B protein (p.Lys208Ile). The lysine residue is highly conserved and there is a moderate physicochemical difference between lysine and isoleucine. The SCN1B gene has multiple clinically relevant isoforms. The p.Lys208Ile variant occurs in alternate transcript NM_001037.4, which corresponds to position c.*5569A>T in NM_199037.3, the primary transcript listed in the Methods. This variant is present in population databases (rs780958012, ExAC 0.009%). Family studies have indicated that an individual with seizures and intellectual disability inherited this variant from an unaffected parent, which suggests that this variant is not likely a primary cause of disease. ClinVar contains an entry for this variant (Variation ID: 470174). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
CeGaT Praxis fuer Humangenetik Tuebingen RCV000996833 SCV001151771 uncertain significance not provided 2017-03-01 criteria provided, single submitter clinical testing
GenomeConnect, ClinGen RCV000709910 SCV000840251 not provided SCN1B-Related Disorder no assertion provided phenotyping only GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.